mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
-0.0018 |
1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0016 |
1 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0013 |
1 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.001 |
1 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.0014 |
1 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.0012 |
1 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.00098 |
1 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.00089 |
1 |